PMV PHARMACEUTICALS, INC. Purchase Commitment, Remaining Minimum Amount Committed
PMV PHARMACEUTICALS, INC. (PMVP) had Purchase Commitment, Remaining Minimum Amount Committed of $0 as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2022-03-01
- 2021-12-31: Purchase Commitment, Remaining Minimum Amount Committed $0.00.
- 2021-09-30: Purchase Commitment, Remaining Minimum Amount Committed $0.00.
- 2021-06-30: Purchase Commitment, Remaining Minimum Amount Committed $0.00.
- 2021-03-31: Purchase Commitment, Remaining Minimum Amount Committed $0.00.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-03 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |